Trial intelligence / Profile preview

PCV7 Effectiveness on Nasopharyngeal Carriage in Chinese Children

NCT02133469Completed

Sponsor
Centers for Disease Control and Prevention
Start
Jun 2012
Primary completion
Apr 2014
Modality
Split/Subunit Vaccines
Countries
1
01

Overview

Randomised, open-label trial of pneumococcal 7-valent conjugate vaccine in pneumococcal disease (2 arms), sponsored by Centers for Disease Control and Prevention. Primary endpoint: Carriage Rate of Vaccine-Serotype S. pneumoniae at 180 days after vaccination. Started Jun 2012; status: completed.

02

Drugs

pneumococcal 7-valent conjugate vaccine
03

Conditions

pneumococcal disease

Beyond the preview

Go deeper on NCT02133469.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02133469.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call